Apteki 36.6 (APTK) EV/EBITDA MSFO (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 35.6 | 9.72 | 27.6 | 16.3 | 10.1 | 8.59 | ||
| Changes by years, y/y, % | +133% | -73% | +184% | -41% | -38% | -8.0% | |||
Apteki 36.6. EV/EBITDA
Apteki 36.6. EV/EBITDA, changes, %
Apteki 36.6 (APTK) EV/EBITDA MSFO (quarter values) |
||||||||
| 2024Q2 | 2024Q4 | 2025Q2 | 2025Q4 | 2026Q2 | LTM ? | |||
| EV/EBITDA | ? | 19.6 | 16.3 | 15.1 | 10.1 | 4.69 | 8.59 | |
| Changes by years, y/y, % | -19% | -41% | -23% | -38% | -69% | |||
| Changes by quarters, q/q, % | -29% | -17% | -7% | -33% | -53% | |||